ABOS

Acumen Pharmaceuticals, Inc. (ABOS) is a clinical-stage biopharmaceutical company based in Charlottesville, Virginia, focused on developing groundbreaking therapies for Alzheimer's disease and other neurodegenerative disorders. Leveraging advanced therapeutic strategies and a robust product pipeline, Acumen is committed to addressing significant unmet medical needs in this critical area of healthcare. As the company advances through its clinical trials, it aims to position itself as a key innovator in Alzheimer's treatment, with the potential to significantly enhance the quality of life for millions affected by these conditions.